HIV-associated lymphoma successfully treated with peripheral blood stem cell transplantation

Experimental Hematology

Volumn 33, Issue 4, 2005, Pages 487-494

  Serrano, David ^a   Carrión, Rafael ^a   Balsalobre, Pascual ^a   Miralles, Pilar ^a   Berenguer, Juan ^a   Buño, Ismael ^a   Gómez Pineda, Alfonso ^a   Ribera, José M ^b   Conde, Eulogio ^c   Díez Martín, José L ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ACICLOVIR; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; ASPARAGINASE; CD34 ANTIGEN; CD4 ANTIGEN; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DIDANOSINE; EFAVIRENZ; ENZYME INHIBITOR; ETOPOSIDE; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROCORTISONE; IFOSFAMIDE; INDINAVIR; LAMIVUDINE; MELPHALAN; METHOTREXATE; PREDNISONE; PROTEINASE INHIBITOR; STAVUDINE; UNINDEXED DRUG; VINCRISTINE;

ADULT; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER GROWTH; CANCER REGRESSION; CELL COUNT; CHEMOSENSITIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE COURSE; FOLLOW UP; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER FAILURE; LYMPHOMA; MALE; MULTICENTER STUDY; NEUTROPHIL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RELAPSE; THROMBOCYTE; TREATMENT OUTCOME; VIRUS LOAD;

EID: 20144368090     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2004.12.008     Document Type: Article

References (36)

1. CDC Current trends revision of the case definition of Acquired Immunodeficiency Syndrome for National Reporting - United States MMWR 34 1985 373 375
2. J.J. Goedert The epidemiology of acquired immunodeficiency syndrome malignancies Semin Oncol 27 2000 390 401
3. M. Spina, S. Sandri, and U. Tirelli Hodgkin's disease in HIV-infected individuals Curr Opin Oncol 11 1999 522 526
4. A.M. Levine Acquired immunodeficiency syndrome-related lymphoma: clinical aspects Semin Oncol 27 2000 442 453
5. L. Seneviratne, B.M. Espina, B.N. Nathwani, J.A. Chan, R.K. Brynes, and A.M. Levine Clinical, immunologic, and pathologic correlates of bone marrow involvement in 291 patients with acquired immunodeficiency syndrome-related lymphoma Blood 98 2001 2358 2363
6. C. Besson, A. Goubar, and J. Gabarre Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy Blood 98 2001 2339 2344
7. O. Kirk, C. Pedersen, and A. Cozzi-Lepri Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy Blood 98 2001 3406 3412
8. G.V. Matthews, M. Bower, S. Mandalia, T. Powles, M.R. Nelson, and B.G. Gazzard Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy Blood 96 2000 2730 2734
9. F.J. Palella Jr., K.M. Delaney, and A.C. Moorman Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators N Engl J Med 338 1998 853 860
10. A. Antinori, A. Cingolani, and L. Alba Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy AIDS 15 2001 1483 1491
11. J.T. Navarro, J.M. Ribera, and A. Oriol Influence of highly active anti-retroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisone Br J Haematol 112 2001 909 915
12. L. Ratner, J. Lee, and S. Tang Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy J Clin Oncol 19 2001 2171 2178
13. J. Bi, B.M. Espina, A. Tulpule, W. Boswell, and A.M. Levine High-dose cytosine-arabinoside and cisplatin regimens as salvage therapy for refractory or relapsed AIDS-related non-Hodgkin's lymphoma J Acquir Immune Defic Syndr 28 2001 416 421
14. M. Spina, E. Vaccher, and S. Juzbasic Human immunodeficiency virus-related non-Hodgkin lymphoma: activity of infusional cyclophosphamide, doxorubicin, and etoposide as second-line chemotherapy in 40 patients Cancer 92 2001 200 206
15. T. Philip, C. Guglielmi, and A. Hagenbeek Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma N Engl J Med 333 1995 1540 1545
16. A. Nademanee, A. Molina, and M.R. O'Donnell Results of high-dose therapy and autologous bone marrow/stem cell transplantation during remission in poor-risk intermediate- and high-grade lymphoma: international index high and high-intermediate risk group Blood 90 1997 3844 3852
17. J.T. Navarro, J.M. Ribera, and A. Oriol International prognostic index is the best prognostic factor for survival in patients with AIDS-related non-Hodgkin's lymphoma treated with CHOP. A multivariate study of 46 patients Haematologica 83 1998 508 513
18. G. Rossi, A. Donisi, S. Casari, A. Re, G. Cadeo, and G. Carosi The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus-related systemic non-Hodgkin lymphoma Cancer 86 1999 2391 2397
19. P. Campbell, H. Iland, J. Gibson, and D. Joshua Syngeneic stem cell transplantation for HIV-related lymphoma Br J Haematol 105 1999 795 798
20. J. Gabarre, N. Azar, B. Autran, C. Katlama, and V. Leblond High-dose therapy and autologous haematopoietic stem-cell transplantation for HIV-1-associated lymphoma Lancet 355 2000 1071 1072
21. A. Krishnan, A. Molina, and J. Zaia Autologous stem cell transplantation for HIV-associated lymphoma Blood 98 2001 3857 3859
22. A. Re, C. Cattaneo, and S. Casari High dose therapy and autologous peripheral blood stem cell transplantation in patients with HIV-associated lymphoma refractory or relapsed after intensive first line chemotherapy [abstract] Blood 98 2001 679a Abstract 2843
23. + high risk lymphoma patients without increasing HIV-1 copies [abstract] Blood 98 2001 679a Abstract 2840
24. N.L. Harris, E.S. Jaffe, and H. Stein A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group Blood 84 1994 1361 1392
25. S.I. Bearman, F.R. Appelbaum, and C.D. Buckner Regimen-related toxicity in patients undergoing bone marrow transplantation J Clin Oncol 6 1988 1562 1568
26. R.F. Little, S. Pittaluga, and N. Grant Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology Blood 101 2003 4653 4659
27. M. Spina, J. Gabarre, and G. Rossi Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection Blood 100 2002 1984 1988
28. L.D. Kaplan, T. Moran, L. Song, B. Tuan, and D. Northfelt Continuous-infusion ifosfamide/Mesna with daily etoposide for refractory HIV-associated non-Hodgkin's lymphoma (NHL) [abstract] J Clin Oncol 17 1998 48a Abstract 185
29. A.M. Levine, L. Seneviratne, and A. Tulpule Incidence and management of AIDS-related lymphoma Oncology 15 2001 629 639
30. R. Weiss, L. Gölkel, and K. Arastéh HIV-related lymphoma: rituximab concomitant to second-line chemotherapy following tumor progression under CHOP or early relapse [abstract] Blood 98 2001 253b Abstract 4744
31. J. Gabarre, S. Choquet, and N. Azar High dose chemotherapy (HDC) with autologous stem cell transplantation (AST) for HIV-associated lymphoma (Ly): a single center report on 14 patients (pts) [abstract] Blood 98 2001 502a Abstract 2092
32. A. Krishnan, J. Zaia, and S.J. Forman Should HIV-positive patients with lymphoma be offered stem cell transplants? Bone Marrow Transplant 32 2003 741 748
33. A. Re, C. Cattaneo, and M. Michieli High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy J Clin Oncol 21 2003 4423 4427
34. C. Haioun, E. Lepage, and C. Gisselbrecht Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol - a groupe d'Etude des lymphomes de l'Adulte study J Clin Oncol 18 2000 3025 3030
35. N. Milpied, E. Deconinck, and F. Gaillard Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support N Engl J Med 350 2004 1287 1295
36. J.A. Sparano, P.H. Wiernik, X. Hu, C. Sarta, D.H. Henry, and H. Ratech Saquinavir enhances the mucosal toxicity of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated nonHodgkin's lymphoma Med Oncol 15 1998 50 57